Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Shifrut

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Cell|September 15, 2023
Modular pooled discovery of synthetic knockin sequences to program durable cell therapiesFranziska Blaeschke, Yan Yi Chen, Ryan Apathy, et al.
Cell Reports|May 12, 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteinsJoseph Hiatt, Devin A Cavero, Michael J McGregor, et al.
Nature Communications|September 27, 2024
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapyAvishai Maliah, Nadine Santana-Magal, Shivang Parikh, et al.
Nature|August 24, 2022
RASA2 ablation in T cells boosts antigen sensitivity and long-term functionJulia Carnevale, Eric Shifrut, Nupura Kale, et al.
Nature|July 12, 2018
Reprogramming human T cell function and specificity with non-viral genome targetingTheodore L Roth, Cristina Puig-Saus, Ruby Yu, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Nature Communications|April 2, 2022
A functional map of HIV-host interactions in primary human T cellsJoseph Hiatt, Judd F Hultquist, Michael J McGregor, et al.
Cell|September 15, 2023
Modular pooled discovery of synthetic knockin sequences to program durable cell therapiesFranziska Blaeschke, Yan Yi Chen, Ryan Apathy, et al.
Cell Reports|May 12, 2021
Efficient generation of isogenic primary human myeloid cells using CRISPR-Cas9 ribonucleoproteinsJoseph Hiatt, Devin A Cavero, Michael J McGregor, et al.
Nature Communications|September 27, 2024
Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapyAvishai Maliah, Nadine Santana-Magal, Shivang Parikh, et al.
Nature|August 24, 2022
RASA2 ablation in T cells boosts antigen sensitivity and long-term functionJulia Carnevale, Eric Shifrut, Nupura Kale, et al.
Nature|July 12, 2018
Reprogramming human T cell function and specificity with non-viral genome targetingTheodore L Roth, Cristina Puig-Saus, Ruby Yu, et al.
Pageof 4